Bernd Buchmann
Inventor
Stats
- 38 US patents issued
- 77 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 38 US Patents Issued
- 77 US Applications Filed
- 416 Total Citation Count
- Mar 5, 2021 Most Recent Filing
- Nov 16, 1990 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT | 1
3 1 5 1 5 5 7 8 2 | 1998
2000 2001 2003 2004 2005 2006 2007 2008 2009 |
SCHERING AKTIENGESELLSCHAFT | 2
1 2 4 4 3 1 1 2 3 1 1 1 | 1990
1991 1993 1994 1995 1996 1997 2000 2001 2002 2004 2005 2006 |
BAYER INTELLECTUAL PROPERTY GMBH | 1
2 2 2 2 3 | 2000
2004 2005 2009 2012 2013 |
BAYER PHARMA AKTIENGESELLSCHAFT | 2
4 2 | 2013
2014 2015 |
Inventor Addresses
Address | Duration |
---|---|
Berlin, DE | Feb 02, 93 - May 01, 01 |
Hohen Neuendorf, DE | May 26, 98 - Jun 22, 23 |
Hohen Neuerdorf, DE | Jun 20, 02 - Oct 31, 06 |
Hohen Nuendorf, DE | Oct 12, 06 - Oct 12, 06 |
NEUENDORR, DE | Jul 31, 03 - Jul 31, 03 |
Neuendorf, DE | Dec 12, 00 - Jan 29, 04 |
Neuendorr, DE | Aug 05, 08 - Jan 15, 09 |
Technology Profile
Technology | Matters | |
---|---|---|
A01K: | ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS | 1 |
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 2 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 62 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2023/0192,700 | 2023 | PYRAZOLOPYRAZINES ACTING ON CANCERS VIA INHIBITION OF CDK12 | 0 |
2023/0113,037 | 2023 | [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES | 0 |
11427578 | 2022 | Substituted pyrrolopyridine-derivatives | 0 |
2022/0047,603 | 2022 | SUBSTITUTED PYRROLOPYRIDINE-DERIVATIVES | 0 |
2020/0246,347 | 2020 | Substituted Pyrrolopyridine-Derivatives | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.